PTSM: Pharmaceutical Technology Sourcing and Management, Oct 2, 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Oct 2, 2013
Contract Manufacturing
Pharma Industry Comments on FDA's Draft Guidance for Contract Manufacturing
By Patricia Van Arnum
Pharmaceutical companies and industry organization provide comments to FDA's draft guidance on contract manufacturing and quality agreements.
CSR and Sustainability Forum
Pharma Industry and WHO Chart Progress on UN Millennium Development Goals
By Patricia Van Arnum
The United Nations discusses the progress in achieving the UN Millennium Development Goals and sets a path for post 2015, and the pharmaceutical industry offers its input.
Pharma News in Global Health and Sustainability
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
Global Feature
Emerging-Market Wage Gap Projected to Narrow
By Patricia Van Arnum
A recent analysis by PricewaterhouseCoopers projects that the wage gap between advanced economics and emerging economies, such as China and India, will shrink significantly by 2030.
Outsourcing
Outsourcing Partnerships for CMC Development
By Jim Miller
Are strategic partnerships in clinical research a model for CMC services?

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here